Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Upcoming Webinar – Developing and Optimizing Cell-based Microplate Assays

28 Nov 2012 - 28 Nov 2012 - Webinar - Online



Bookmark and Share


Looking to perform a microplate cell-based assay for the first time or would like to develop a higher throughput for your current cell-based assay? On November 28th at noon EST a webinar will be hosted by Drug Discovery and Development and BMG LABTECH, the Microplate Reader Company, to discuss developing and optimizing cell-based assays in a microplate format.
 
Many researchers look to translate their biochemical microplate assay to a cell-based format because biochemical assays can be limiting and misleading in the information that they provide. This growing trend has caused a surge in the development of many new cell-based microplate assays, as well as new developments in the instrumentation used to optimize these cell-based microplate assays.

In this webinar, three speakers will present some of the different aspects involved in developing and optimizing cell-based assays in a microplate format. Please join us to learn more about:

•    Optimizing Measurements for Microplate Cell-based Assays; Catherine Wark, BMG LABTECH, UK
•    Miniaturization and Automation of HTRF® Cell-based Assays with the Echo® Liquid Handler; Bonnie Edwards, Labcyte, Inc., USA
•    Identification and characterization of allosteric modulators of GPCRs using an HTRF® cellular assay; Jeff Jerman, PhD, MRC Technology, UK


Join us on: Wednesday, November 28th at 12:00 EST. Participation in this webinar is free and we look forward to you joining us. For more information visit: http://www.bmglabtech.com/webinar/cell-based-assays.cfm.



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!